Trends in Cardiovascular Medicine
Volume 18, Issue 6 , Pages 224-228, August 2008

Foxc2 Transcription Factor: A Newly Described Regulator of Angiogenesis

  • Tsutomu Kume

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Dr. Tsutomu Kume, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 332 PRB, 2220 Pierce Ave, Nashville, Tennessee 37232-6300, USA. Tel.: (+1) 615 936 2884; fax: (+1) 615 936 1872

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA

Received 3 October 2008; received in revised form 7 November 2008; accepted 10 November 2008.

Angiogenesis is a critical process to form new blood vessels from preexisting vessels under physiologic and pathologic conditions and involves cellular and morphologic changes such as endothelial cell proliferation, migration, and vascular tube formation. Despite evidence that angiogenic factors, including vascular endothelial growth factor and Notch, control various aspects of angiogenesis, the molecular mechanisms underlying gene regulation in blood vessels and surrounding tissues are not fully understood. Importantly, recent studies demonstrate that Forkhead transcription factor Foxc2 directly regulates expression of various genes involved in angiogenesis, CXCR4, integrin β3, Delta-like 4 (Dll4), and angiopoietin 2, thereby controlling angiogenic processes. Thus, Foxc2 is now recognized as a novel regulator of vascular formation and remodeling. This review summarizes current knowledge about the function of Foxc2 in angiogenesis and discusses prospects for future research in Foxc2-mediated pathologic angiogenesis in cardiovascular disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(08)00126-6

doi:10.1016/j.tcm.2008.11.003

Trends in Cardiovascular Medicine
Volume 18, Issue 6 , Pages 224-228, August 2008